JP2011136969A - Extract from saussurea involucrata, food/drink composition and basic cosmetic composition each containing the same - Google Patents

Extract from saussurea involucrata, food/drink composition and basic cosmetic composition each containing the same Download PDF

Info

Publication number
JP2011136969A
JP2011136969A JP2009299220A JP2009299220A JP2011136969A JP 2011136969 A JP2011136969 A JP 2011136969A JP 2009299220 A JP2009299220 A JP 2009299220A JP 2009299220 A JP2009299220 A JP 2009299220A JP 2011136969 A JP2011136969 A JP 2011136969A
Authority
JP
Japan
Prior art keywords
extract
food
cetsurenka
basic cosmetic
cosmetic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009299220A
Other languages
Japanese (ja)
Inventor
Hung Lin Chen
陳鴻霖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAIICHI KOKUSAI KAGI KOFUN YUGENKOSHI
Original Assignee
DAIICHI KOKUSAI KAGI KOFUN YUGENKOSHI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAIICHI KOKUSAI KAGI KOFUN YUGENKOSHI filed Critical DAIICHI KOKUSAI KAGI KOFUN YUGENKOSHI
Priority to JP2009299220A priority Critical patent/JP2011136969A/en
Publication of JP2011136969A publication Critical patent/JP2011136969A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an extract from Saussurea involucrata enabling itself to be incorporated, as an active ingredient for protecting the liver, in health food or pharmaceutical compositions. <P>SOLUTION: The extract from Saussurea involucrata includes: at least, flavonoids; chlorogenic acid; and syringin; and is to be used for preventing or treating hepatopathy, articular rheumatism, hypertension, hyperglycemia or hyperlipemia. Besides, the extract can be served as an active ingredient for health food or pharmaceuticals in the form of powder, drink, capsules or tablets. Further, the extract has moisturizing anti-suntan effect simultaneously, thus enabling serving as an active ingredient for basic cosmetics, makeup cosmetics or agents for external use in the form of gel type, water-including-oil emulsified type or oil-including-water emulsified type. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、セツレンカ抽出物に関し、特に肝臓疾患、関節リウマチ、高血圧、高血糖または高脂血症を予防または治療するセツレンカ抽出物に関する。   The present invention relates to an extract of cetsurenka, and more particularly to an extract of sturlenca for preventing or treating liver disease, rheumatoid arthritis, hypertension, hyperglycemia or hyperlipidemia.

肝癌は、肝細胞が異常に変化する疾患であり、制御されない異常分裂により癌化腫瘍を形成する。肝癌の形成は、B型およびC型肝炎への感染と関連する。台湾人のB型肝炎キャリア率は約16%であり、すなわち約360万人以上が潜在的な肝疾患のリスクを有している。科学家は、B型肝炎に感染している人の10〜20%が肝癌を罹患すると推計している。台湾では、肝癌患者の80〜90%がB型肝炎に感染したことがある。C型肝炎と肝癌との間の確実な関係は、研究中である。   Liver cancer is a disease in which hepatocytes change abnormally, and forms a cancerous tumor by uncontrolled abnormal division. The formation of liver cancer is associated with infection with hepatitis B and C. Taiwanese hepatitis B carrier rate is about 16%, that is, more than about 3.6 million people are at risk for potential liver disease. Scientists estimate that 10-20% of people infected with hepatitis B will have liver cancer. In Taiwan, 80-90% of liver cancer patients have been infected with hepatitis B. A reliable relationship between hepatitis C and liver cancer is under study.

現在、ある種の肝疾患に罹った人が、比較的高い確率で原発性肝癌を罹患することが知られている。例えば、肝硬変(進行性の肝障害によりもたらされる疾患)の患者のうち、5〜10%が最終的に肝癌を罹患する。睡眠不足、過量飲酒および栄養失調などのよくない生活習慣が、いずれも肝硬変および肝癌をもたらすとしている研究もある。   It is now known that people with certain types of liver disease suffer from primary liver cancer with a relatively high probability. For example, among patients with cirrhosis (a disease caused by progressive liver damage), 5-10% eventually suffer from liver cancer. Some studies suggest that poor lifestyle habits, such as lack of sleep, excessive drinking and malnutrition, all lead to cirrhosis and liver cancer.

肝臓は、人体の最も重要な解毒器官であり、人体で唯一再生可能な器官でもある。ライフスタイルの関係により、多くの人が若い頃に仕事で充分に休息をとることができず、歳をとってから、裕福になっても金銭で健康を取り戻すことはできないことに気づく。肝癌の死亡率は高く、現在、台湾人の肝臓をいたわる意識が徐々に台頭してきており、各種の肝臓によい健康食品が次々と登場している。   The liver is the most important detoxifying organ of the human body and the only reproducible organ in the human body. Because of lifestyle relationships, many people find that they cannot get enough rest at work when they are young, and they cannot recover their health with money even if they become wealthy after they get older. Liver cancer has a high mortality rate, and Taiwan's liver consciousness is gradually emerging. Good health foods for various livers are appearing one after another.

公知技術の各種の課題に鑑み、これを解決するため、本発明人は、長年の研究開発と多くの実務経験に基づき、前記欠点を改善する実現方法および根拠として、セツレンカ抽出物を提供する。   In order to solve this problem in view of various problems in the known technology, the present inventor provides cetelecan extract as a realization method and a basis for improving the above-mentioned drawbacks based on many years of research and development and many practical experiences.

これに鑑み、本発明は、肝臓を保護する有効成分として、健康食品または医薬組成物に添加可能なセツレンカ抽出物を提供することを目的とする。   In view of this, an object of the present invention is to provide a cetsurenka extract that can be added to health foods or pharmaceutical compositions as an active ingredient for protecting the liver.

本発明の目的に基づき、少なくともフラボノイドと、クロロゲン酸と、シリンギンとを含み、肝臓疾患、関節リウマチ、高血圧、高血糖または高脂血症を予防または治療する有効成分とすることが可能なセツレンカ抽出物を提供する。   In accordance with the object of the present invention, cetulenca extract containing at least a flavonoid, chlorogenic acid and syringin, which can be used as an active ingredient for preventing or treating liver disease, rheumatoid arthritis, hypertension, hyperglycemia or hyperlipidemia. Offer things.

また、本発明は、肝臓疾患、関節リウマチ、高血圧、高血糖または高脂血症の予防または治療に用いるセツレンカ抽出物を含む飲食品組成物をさらに提供する。   In addition, the present invention further provides a food and beverage composition comprising a cetsurenka extract used for the prevention or treatment of liver disease, rheumatoid arthritis, hypertension, hyperglycemia or hyperlipidemia.

また、本発明は、基礎化粧品、メーキャップ化粧品または外用剤に応用可能なセツレンカ抽出物を含む保湿剤をさらに提供する。   In addition, the present invention further provides a moisturizing agent containing a cetsurenka extract applicable to basic cosmetics, makeup cosmetics, or external preparations.

上述したように、本発明によりセツレンカ抽出物は、以下の利点を有する。
(1)このセツレンカ抽出物は、肝臓を保護する効果を有し、健康食品または医薬品の有効成分とすることができる。
(2)このセツレンカ抽出物は、保湿日焼け止めの効果を有し、基礎化粧品、メーキャップ化粧品または外用剤の有効成分とすることができる。
As described above, the cethuren extract according to the present invention has the following advantages.
(1) This cetsurenka extract has an effect of protecting the liver, and can be used as an active ingredient of health foods or pharmaceuticals.
(2) This Ceturenka extract has a moisturizing sunscreen effect and can be used as an active ingredient in basic cosmetics, makeup cosmetics or external preparations.

テンザンセツレンは、キク科トウヒレン属の植物(Saussureu involucrata Kar.et Kin)であり、雪荷花とも呼ばれる。多年草であり、唯一雪線上で生長できる大型草本植物である。セツレンカは、新疆ウイグル自治区内の天山山脈、アルタイ山脈、崑崙山脈に分布しており、海抜3000メートル以上の雪山の石の隙間の中に生長し、辛い味で温める作用がある。   Tenzanseturen is a plant belonging to the genus Spruce genus Sausureu involukurata Kar. Et Kin, and is also called snow-capped flower. It is a perennial and the only large herbaceous plant that can grow on the snow line. Seturenka is distributed in the Tianshan Mountains, Altai Mountains, and Dunhuang Mountains in the Xinjiang Uygur Autonomous Region, grows in the crevices of snowy mountains over 3000 meters above sea level, and has the effect of warming with a spicy taste.

本発明のセツレンカ抽出物は、以下のステップにより得られる。
1.乾燥セツレンカ粉末を提供する。
2.1−ブタノールでセツレンカ粉末を抽出する。
3.セツレンカ抽出物を1−ブタノールから分離する。
The certurica extract of the present invention is obtained by the following steps.
1. Provide dry cetsurenka powder.
2.1 Extract cetsurenka powder with 1-butanol.
3. Separate the cetsurenka extract from 1-butanol.

このセツレンカ抽出物は、粉末または抽出液の仕様とすることができる。   This cetsurenka extract can be in powder or extract specifications.

本発明のセツレンカ抽出物は、少なくともフラボノイドと、クロロゲン酸と、シリンギンとを含み、肝臓疾患、関節リウマチ、高血圧、高血糖または高脂血症などを予防または治療する効果を有する。フラボノイドの基本構造は、15の炭素原子が3個の環に配列したものであり、フラボノイドの主な違いは酸素を含む環にあり、構造により、フラボン類(Flavones)、フラボノール類(Flavonols)、イソフラボン類(Isoflavones)、フラバノン類(Flavanones)、アントシアニン(Anthocyanin)の5大分類に分かれる。フラボノイドは、天然の酸化防止剤であり、世界で最も強力な酸化防止剤として認められており、抗酸化能力は、ビタミンEの50倍、ビタミンCの20倍である。フラボノイドの分子構造は小さく、水溶性を有し、人体に吸収されやすい。蓄積性がなく、体内のラジカルを除去することができ、肝臓保護の主要成分である。クロロゲン酸(Chlorlgenic Acid)は、コーヒー豆の中に存在し、未焙煎のコーヒー豆中の含量は45%以上にも達する。クロロゲン酸は、高い抗酸化作用を有し、活性酸素を抑制し、癌および生活習慣病の予防に有効であるだけでなく、毛細血管を保護し、血栓を予防することもできる。クロロゲン酸は、非常に強い除去能力を有し、ラジカルに対抗する能力が極めてよく、効果的に破壊力が最も強いヒドロキシルラジカルを除去または抑制することができる。シリンギンは、強力な抗肝毒性薬であり、ミクロソーム酵素系の酵素活性を回復し、脂質過酸化作用を抑制することにより、肝毒性物質の代謝を促進し、肝機能を改善して正常化させることができる。   The cetsurenka extract of the present invention contains at least a flavonoid, chlorogenic acid, and syringin, and has an effect of preventing or treating liver disease, rheumatoid arthritis, hypertension, hyperglycemia or hyperlipidemia. The basic structure of flavonoids is a structure in which 15 carbon atoms are arranged in three rings. The main difference of flavonoids is in the ring containing oxygen. Depending on the structure, flavones (Flavones), flavonols (Flavonols), It is divided into five major classifications: isoflavones, flavanones, and anthocyanins. Flavonoids are natural antioxidants and are recognized as the most powerful antioxidants in the world, with antioxidant capacity 50 times that of vitamin E and 20 times that of vitamin C. Flavonoids have a small molecular structure, water solubility, and are easily absorbed by the human body. It is not accumulative, can remove radicals in the body, and is a major component of liver protection. Chlorogenic acid is present in coffee beans, and the content in unroasted coffee beans reaches 45% or more. Chlorogenic acid not only has high antioxidant action, suppresses active oxygen, is effective in preventing cancer and lifestyle-related diseases, but can also protect capillaries and prevent thrombus. Chlorogenic acid has a very strong scavenging ability, has a very good ability to resist radicals, and can effectively remove or suppress hydroxyl radicals having the strongest destructive power. Syringin is a powerful anti-hepatotoxic drug that restores the enzyme activity of the microsomal enzyme system and suppresses lipid peroxidation, thereby promoting the metabolism of hepatotoxic substances and improving and normalizing liver function. be able to.

本発明のセツレンカ抽出物は、アミノ酸、ウンベリフェロン、スコポレチン、アピゲニン、シトステロールおよびコルヒチンのうちの1種または2種以上の混合物をさらに含むことができる。アミノ酸は、人体のpHを効果的に調節し、人体の免疫力を増強し、疲労を防止することができる。ウンベリフェロンは、顕著な抗菌、降圧、鎮静、鎮痙作用を有する。スコポレチンは、アレルギー反応抑制、消炎、鎮痛、痰切りの作用を有し、慢性気管支炎の治療に極めて優れた効果を有する。アピゲニンは、平滑筋鎮痙および抗胃潰瘍の作用を有する。シトステロールは、血圧および肝臓中のコレステロールを下げる作用を有する。コルヒチンは、細胞有糸分裂の典型的な代表であり、癌細胞の増殖を抑制することができ、臨床において、癌の治療に用いられており、特に乳癌に対してある程度の治療効果を有し、皮膚癌、白血病に対してもある程度の作用を有する。   The cetsurenka extract of the present invention may further comprise one or a mixture of two or more of amino acids, umbelliferone, scopoletin, apigenin, sitosterol and colchicine. Amino acids can effectively adjust the pH of the human body, enhance the immunity of the human body, and prevent fatigue. Umbelliferone has significant antibacterial, antihypertensive, sedative, and antispasmodic effects. Scopoletin has the effects of suppressing allergic reactions, anti-inflammatory, analgesic, and phlegm cutting, and has an extremely excellent effect in the treatment of chronic bronchitis. Apigenin has smooth muscle spasm and anti-gastric ulcer effects. Sitosterol has the effect of lowering blood pressure and cholesterol in the liver. Colchicine is a typical representative of cell mitosis, can suppress the growth of cancer cells, is clinically used for the treatment of cancer, and has a certain therapeutic effect especially against breast cancer Also has some effects on skin cancer and leukemia.

本発明によるセツレンカ抽出粉末50グラム、微結晶セルロース25グラムおよびラクトース25グラムを均一に混ぜて容積500ミリリットルのカプセルに充填した。肝機能数値(GOT、GPT)が高すぎる夜勤作業員15人にテンザンセツレンカプセルを1日1錠服用させ、30日後に測定した結果、すべての人の肝機能数値がいずれも初期値よりも低く、かつそのうち6人の肝機能数値がすでに正常範囲内にあった。また、本発明のセツレンカ抽出物は、散剤、飲料、カプセルまたは錠剤とすることができる。   A capsule of 500 ml capacity was prepared by uniformly mixing 50 grams of Selecan extract powder, 25 grams of microcrystalline cellulose and 25 grams of lactose according to the present invention. Liver function values (GOT, GPT) were too high. 15 night shift workers were given 10 tablets of Tenzan cetrene capsule per day and measured 30 days later. As a result, all the liver function values were higher than the initial values. The liver function values of 6 of them were already within the normal range. Moreover, the cetsurenka extract of this invention can be made into a powder, a drink, a capsule, or a tablet.

本発明によるセツレンカ抽出液50グラム、増粘剤3グラムおよび水47グラムを均一に混ぜてゲル状基礎化粧品とした。女性会社員15人に毎日朝晩顔に塗布させ、30日後に測定し、皮膚計測機器MPA580のCorneometer(R)CM825プローブで表皮水分測定を行った。30日後に測定した結果、すべての人の表皮水分含量にいずれも上昇現象が認められ、かつ平均表皮水分含量は、使用前の61.3から使用後の65.4まで上昇し、6.91%増加した。   A gel-like basic cosmetic product was prepared by uniformly mixing 50 grams of Selenium extract according to the present invention, 3 grams of thickener and 47 grams of water. Fifteen female office workers were applied to the face every morning and evening, measured 30 days later, and epidermis moisture was measured with a Corneometer (R) CM825 probe of skin measuring instrument MPA580. As a result of measurement after 30 days, an increase phenomenon was observed in the skin water content of all persons, and the average skin water content increased from 61.3 before use to 65.4 after use, to 6.91. % Increase.

上述した内容は、例示的なものでしかなく、制限的なものではない。本発明の主旨および範疇を逸脱せずに行われた同等の修正または変更は、いずれも特許請求の範囲内に含まれるものとする。   The contents described above are merely illustrative and not restrictive. All equivalent modifications or changes made without departing from the spirit and scope of the invention are intended to be included within the scope of the claims.

Claims (12)

少なくともフラボノイドと、クロロゲン酸と、シリンギンとを含み、肝臓疾患、関節リウマチ、高血圧、高血糖または高脂血症の予防または治療に用いられるセツレンカ抽出物。 A cetulenca extract containing at least a flavonoid, chlorogenic acid, and syringin and used for the prevention or treatment of liver disease, rheumatoid arthritis, hypertension, hyperglycemia or hyperlipidemia. アミノ酸、ウンベリフェロン、スコポレチン、アピゲニン、シトステロールおよびコルヒチンのうちの1種または2種以上の混合物をさらに含む請求項1に記載のセツレンカ抽出物。 The cetsurenka extract according to claim 1, further comprising one or a mixture of two or more of amino acids, umbelliferone, scopoletin, apigenin, sitosterol and colchicine. 粉末または液体の形式である請求項1または請求項2に記載のセツレンカ抽出物。 3. A certurica extract according to claim 1 or 2 in powder or liquid form. 1−ブタノールを抽出溶剤とした請求項1ないし請求項3のいずれか一項に記載のセツレンカ抽出物。 The cetsurenka extract according to any one of claims 1 to 3, wherein 1-butanol is used as an extraction solvent. 請求項1に記載のセツレンカ抽出物を含む飲食品組成物。 The food-drinks composition containing the cetsurenka extract of Claim 1. アミノ酸、ウンベリフェロン、スコポレチン、アピゲニン、シトステロールおよびコルヒチンのうちの1種または2種以上の混合物をさらに含む請求項5に記載の飲食品組成物。 The food or beverage composition according to claim 5, further comprising one or a mixture of two or more of amino acids, umbelliferone, scopoletin, apigenin, sitosterol and colchicine. 散剤、飲料、カプセルまたは錠剤のいずれかの形式である請求項5または請求項6に記載の飲食品組成物。 The food / beverage composition according to claim 5 or 6, wherein the food / beverage composition is in the form of powder, beverage, capsule or tablet. 肝臓疾患、関節リウマチ、高血圧、高血糖または高脂血症の予防または治療に用いられる請求項5ないし請求項7のいずれか一項に記載の飲食品組成物。 The food or beverage composition according to any one of claims 5 to 7, which is used for prevention or treatment of liver disease, rheumatoid arthritis, hypertension, hyperglycemia or hyperlipidemia. 請求項1に記載のセツレンカ抽出物を含む基礎化粧品組成物。 A basic cosmetic composition comprising the cetsurenka extract according to claim 1. アミノ酸、ウンベリフェロン、スコポレチン、アピゲニン、シトステロールおよびコルヒチンのうちの1種または2種以上の混合物をさらに含む請求項9に記載の基礎化粧品組成物。 The basic cosmetic composition according to claim 9, further comprising one or a mixture of two or more of amino acids, umbelliferone, scopoletin, apigenin, sitosterol and colchicine. ゲル状、水中油型乳化状または油中水型乳化状である請求項9または請求項10に記載の基礎化粧品組成物。 The basic cosmetic composition according to claim 9 or 10, which is a gel, an oil-in-water emulsion, or a water-in-oil emulsion. 保湿、日焼け止めまたは美白の用途とする請求項9ないし請求項11のいずれか一項に記載の基礎化粧品組成物。 The basic cosmetic composition according to any one of claims 9 to 11, which is used for moisturizing, sunscreen or whitening.
JP2009299220A 2009-12-29 2009-12-29 Extract from saussurea involucrata, food/drink composition and basic cosmetic composition each containing the same Withdrawn JP2011136969A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009299220A JP2011136969A (en) 2009-12-29 2009-12-29 Extract from saussurea involucrata, food/drink composition and basic cosmetic composition each containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009299220A JP2011136969A (en) 2009-12-29 2009-12-29 Extract from saussurea involucrata, food/drink composition and basic cosmetic composition each containing the same

Publications (1)

Publication Number Publication Date
JP2011136969A true JP2011136969A (en) 2011-07-14

Family

ID=44348767

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009299220A Withdrawn JP2011136969A (en) 2009-12-29 2009-12-29 Extract from saussurea involucrata, food/drink composition and basic cosmetic composition each containing the same

Country Status (1)

Country Link
JP (1) JP2011136969A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012020964A (en) * 2010-07-14 2012-02-02 Arsoa Honsya Corp Glutathione production promoter, and drug, food or cosmetic having glutathione production promoting action
CN103305454A (en) * 2012-03-14 2013-09-18 中国医学科学院药物研究所 Method for producing Syringin, chlorogenic acid and 1, 5-dicaffeoylquinic acid by cell culture of herba saussureae involucratae
CN107412241A (en) * 2017-09-25 2017-12-01 陕西中药研究所 A kind of Syringin pharmaceutical composition and its application in cervicitis is treated
CN108079002A (en) * 2018-02-02 2018-05-29 陕西新药技术开发中心 Application of the Syringin in tumour drug combination is treated
JP6919960B1 (en) * 2021-06-03 2021-08-18 株式会社ナボカルコスメティックス New phenylpropanoid compound

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012020964A (en) * 2010-07-14 2012-02-02 Arsoa Honsya Corp Glutathione production promoter, and drug, food or cosmetic having glutathione production promoting action
CN103305454A (en) * 2012-03-14 2013-09-18 中国医学科学院药物研究所 Method for producing Syringin, chlorogenic acid and 1, 5-dicaffeoylquinic acid by cell culture of herba saussureae involucratae
CN107412241A (en) * 2017-09-25 2017-12-01 陕西中药研究所 A kind of Syringin pharmaceutical composition and its application in cervicitis is treated
CN108079002A (en) * 2018-02-02 2018-05-29 陕西新药技术开发中心 Application of the Syringin in tumour drug combination is treated
JP6919960B1 (en) * 2021-06-03 2021-08-18 株式会社ナボカルコスメティックス New phenylpropanoid compound

Similar Documents

Publication Publication Date Title
US6602526B2 (en) Oral compositions containing lotus
KR101776071B1 (en) Composition containing red sword bean extract for anti-aging and whitening
US20220287956A1 (en) Composition containing cirsium japonicum extract as active ingredient for stimulating melanogenesis
KR102142930B1 (en) A composition for promoting melanin synthesis comprising flower extract of milk thistle
US20090169651A1 (en) Anti-skin damage compositions with complimentary dual mode of action
KR20150050310A (en) Composition for improving skin conditions comprising artemisiae annuae herba, neem leaf, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same
JP2011136969A (en) Extract from saussurea involucrata, food/drink composition and basic cosmetic composition each containing the same
WO2011115061A1 (en) Hyaluronic acid production promoter
JP2010024222A (en) Collagen production promoter, hyaluronic acid production promoter, and collagen production and hyaluronic acid production promoter
KR100776755B1 (en) Composition comprising crude drug extract showing anti-itching effect
JP2011195534A (en) Hyaluronic acid production promoter, anti-ageing agent and wrinkle-ameliorating agent
KR20190064714A (en) Anti-inflammatory agent containing backhousia citriodora extract
KR102374994B1 (en) Cosmetic Compositions Having Extracts of JEJU Lava Seawater and JEJU Sasa querlpaertensis Nakai and Preparation Methods Using Thereof
JP2007045733A (en) Hyaluronidase inhibitor
CN106999528A (en) For preventing hair loss or stimulating the composition for including high mountain radix scutellariae extract of natural on-off cycles of hair growth
JP2011195533A (en) Fibroblast proliferation promoter and anti-ageing agent
KR101367703B1 (en) Composition of cosmetic and treating skin disease
KR102379698B1 (en) A composition for skin whitening or regeneration comprising Melandrium firmum extract
JP4716497B2 (en) External preparation for skin and hyaluronidase inhibitor
Yoseph et al. The Importance of Fermented Active for Anti Aging incosmetics Product
KR20140137796A (en) Food Composition for Reducing Joint Pain Comprising Achyranthes japonica Nakai, Sorbus commixta and Soybean Extract
KR20120090137A (en) Cosmetic compositions for promoting lipolysis and removing cellulite
KR20180050798A (en) Cosmetic compositions containing Zingiberaceae extracts for skin homeostasis and nontoxicity and manufacturing method thereof
JP4413272B1 (en) Hyaluronic acid production promoter
KR20210091449A (en) Composition for treating or preventing acne comprising elaeagnus umbellata leaves extract

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20130305